Stay updated on China CKD Study of FG-4592 Clinical Trial
Sign up to get notified when there's something new on the China CKD Study of FG-4592 Clinical Trial page.

Latest updates to the China CKD Study of FG-4592 Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedNew operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.SummaryDifference5%
- Check23 days agoChange DetectedAdded a new page revision (v3.1.0) and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the previous content.SummaryDifference0.6%
- Check37 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.3%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.3%
- Check52 days agoChange DetectedThe web page has added significant content related to drug safety, including specific mentions of roxadustat and counterfeit drugs, while also updating the facility name and location to Dalian, China. Several previous entries related to various diseases and locations have been removed.SummaryDifference4%
- Check66 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to China CKD Study of FG-4592 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the China CKD Study of FG-4592 Clinical Trial page.